Barry A. Berkowitz

We are a unique biopharma innovation company. We are developing novel therapeutics and processes for a variety of diseases including cancer, acute inflammation, and other serious disorders. We are also developing a novel chemical synthesis platform for an untapped class of natural products with broad potential in therapeutics and consumer goods. We offer an unparalleled ecosystem of academic relationships and know-how and excel at translational R&D. Our team has been instrumental in the development of nearly twenty marketed drugs. We internally fund and advance projects to a significant value point, for example IND ready or proof of concept. This enables us to rapidly develop and offer an advanced opportunity to our downstream partners and investors.